Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events

Am J Med. 2004 Oct 1;117(7):528-30. doi: 10.1016/j.amjmed.2004.07.037.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aspirin / adverse effects
  • Aspirin / therapeutic use*
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / prevention & control*
  • Guideline Adherence / standards*
  • Humans
  • Japan / epidemiology
  • Patient Selection
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Practice Guidelines as Topic*
  • Primary Prevention / standards*
  • Risk Assessment*
  • United States / epidemiology

Substances

  • Platelet Aggregation Inhibitors
  • Aspirin